Effect of history and exam in predicting electrodiagnostic outcome among patients with suspected lumbosacral radiculopathy

American Journal of Physical Medicine and Rehabilitation

Volumn 79, Issue 1, 2000, Pages 60-68

  Lauder, Tamara D ^a   Dillingham, Timothy R ^b   Andary, Michael ^c   Kumar, Shashi ^d   Pezzin, Liliana E ^b   Stephens, Ronald T ^e   Shannon, Steven ^f  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d MADIGAN ARMY MEDICAL CENTER   (United States)

^e WOMACK ARMY MEDICAL CENTER   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Electrodiagnosis; Electromyography; Lumbar Spine; Lumbosacral Radiculopathy; Physical Examination

Indexed keywords

BIOMEDICAL ENGINEERING; MUSCLE; NEUROLOGY; PATIENT MONITORING;

ELECTRODIAGNOSIS; LUMBAR SPINE; LUMBOSACRAL RADICULOPATHY;

ELECTROMYOGRAPHY;

ADOLESCENT; ADULT; AGED; ELECTRODIAGNOSIS; ELECTROMYOGRAM; HUMAN; LEG PAIN; LOW BACK PAIN; LUMBOSACRAL SPINE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MUSCLE WEAKNESS; PARESTHESIA; PHYSICAL EXAMINATION; RADICULOPATHY; REVIEW; SKIN TINGLING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; HUMANS; LUMBOSACRAL PLEXUS; MEDICAL HISTORY TAKING; MIDDLE AGED; NEURAL CONDUCTION; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADICULOPATHY; SENSITIVITY AND SPECIFICITY;

EID: 0033977792     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200001000-00013     Document Type: Review

References (26)

1. Turpie AGG, Levine MN, Hirsh J, et al: A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925-9
2. Clagett GP, Anderson FA Jr, Heit J, et al: Prevention of venous thromboembolism. Chest 1995;108(4 Suppl):312S-34S
3. Stringer MD, Steadman CA, Hedges AR, et al: Deep vein thrombosis after elective knee surgery: an incidence study in 312 patient. J Bone Joint Surg Br 1989; 71:492-7
4. The European Atrial Fibrillation Trial Study Group: Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-10
5. Stroke Prevention in Atrial Fibrillation Investigators: Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 1994; 343:687-91
6. Smith P, Arnesen H, Holme I: The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990;323:147-52
7. Cannegieter SC, Rosendaal FR, Wintzen AR, et al: Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-7
8. Ryan EM (ed): Pulmonary embolism and deep vein thrombosis (forum). Risk Management Foundation of the Harvard Medical Institutions 1994;15:2-18
9. Fihn SD: Aiming for safe anticoagulation. N Engl J Med 1995;333:54-5
10. Ansell JE, Patel N, Ostrovsky D, et al: Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-9
11. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323: 1505-11
12. Hirsh J, Dalen JE, Deykin D, et al: Oral anticoagulants: mechanisms of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(4-Suppl):231S-246S
13. Hirsh J: Optimal intensity and monitoring warfarin. Am J Cardiol 1995;75: 39B-42B
14. Hylek EM, Skates SJ, Sheehan MA, et al: An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996; 335:540-56
15. Hylek EM, Singer DE: Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120:897-902
16. Cunningham MT, Olson JD: Low interinstrument variability of the internationalized normalized ratio with the coagamate X2/Simplastin excel system. Am J Clin Pathol 1996;105:301-4
17. Stein J: The risk of bleeding for stroke patients receiving anticoagulation during rehabilitation. Arch Phys Med Rehabil 1996;77:977
18. Anonymous: Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation randomized clinical trial. Lancet 1996;348:633-822
19. Cifu DX, Kaelin DL, Wall BE: Deep venous thrombosis: incidence on admission to a brain injury rehabilitation program. Arch Phys Med Rehabil 1996;77: 1182-5
20. Hull R, Raskob G, Pineo G, et al: A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for the prophylaxis against deepvein thrombosis after hip or knee implantation. N Engl J Med 1993;329: 1370-6
21. Hull RD, Raskob GE, Pineo GF, et al: Subcutaneous low-molecular-weight heparin vs. warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. Arch Intern Med 1997;157: 298-303
22. Guidelines for Regulating Coumadin Dosage by the INR. Boston, Massachusetts General Hospital, 1995
23. O'Reilly RA: Warfarin metabolism and drug-drug interactions, in Wessler S, Becker CG, Nemerson Y (eds): The New Dimension of Warfarin Prophylaxis: Advances in Experimental Medicine and Biology. New York, Plenum, 1986:205-12
24. Sun J, Chang MW: Initiation of warfarin dosages using computer modeling. Arch Phys Med Rehabil 1995;76:453-6
25. Galloway MJ, Foggin JJ, Dixon S: Introduction of computer assisted control of oral anticoagulation in general practice. J Clin Pathol 1995;48:1144-6
26. Poller L, Wright D, Rowlands M: Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993;46:299-303